Market revenue in 2023 | USD 138.7 million |
Market revenue in 2030 | USD 193.6 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Topical |
Fastest growing segment | Topical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oral, Topical |
Key market players worldwide | GSK PLC, Abbott Laboratories, Pfizer Inc, Bausch Health Companies Inc, Bayer AG, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Merck & Co Inc, Novartis AG ADR, Sun Pharmaceutical Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to onychomycosis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 57.68% in 2023. Horizon Databook has segmented the UK onychomycosis market based on oral, topical covering the revenue growth of each sub-segment from 2018 to 2030.
The UK market is expected to grow significantly owing to the rising investments and developments in pharmaceuticals for treating onychomycosis. Industry participants operating in the UK are undergoing collaborations & partnerships to increase access to treatments in the country.
For instance, in February 2021, NovaBiotics Ltd., a UK-based anti-infectives biotechnology company, collaborated with an undisclosed partner to commercialize its NP213 peptide in a topical nail fungus treatment.
Such collaborations by leading domestic players are expected to boost the market competition in the UK. Furthermore, the companies involved in the distribution and development of onychomycosis treatments and medications are attracting investments.
Horizon Databook provides a detailed overview of country-level data and insights on the UK onychomycosis market , including forecasts for subscribers. This country databook contains high-level insights into UK onychomycosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account